ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Sensory Morbidity Following Breast Surgery

This study is currently recruiting participants.
Verified by Memorial Sloan-Kettering Cancer Center, March 2008

Sponsored by: Memorial Sloan-Kettering Cancer Center
Information provided by: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00625924
  Purpose

The goal of the study is measure breast senasations after breast surgery. The results of this study will help surgeons better understand breast sensations and may improve the way surgery is done.


Condition Intervention
Breast Cancer
Behavioral: questionnaires

Genetics Home Reference related topics:   breast cancer   

MedlinePlus related topics:   Breast Cancer    Cancer   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Case-Crossover, Retrospective
Official Title:   Sensory Morbidity Following Breast Surgery

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • To evaluate the prevalence, severity and level of distress of subjective breast sensations following mastectomy and postmastectomy reconstruction. [ Time Frame: conclusion of the study ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To compare sensory morbidity following three types of breast surgery: tissue expander/implant breast reconstruction, autogenous tissue reconstruction, and no reconstruction. [ Time Frame: conclusion of the study ] [ Designated as safety issue: No ]

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment:   300
Study Start Date:   February 2008
Estimated Study Completion Date:   February 2010
Estimated Primary Completion Date:   February 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts Assigned Interventions
1
autogenous tissue breast reconstruction
Behavioral: questionnaires
Patients will be evaluated at one time point using the Breast Sensation Assessment Score (BSAS©), the SF-36 Health Survey, the MSKCC BREAST Q, the Brief Pain Inventory, the Hopwood Body Image Scale, the Profile of Mood States - Brief Version (POMS - BRF), and the 'Patient Demographic and Treatment Information Form'
2
tissue expander/implant breast reconstruction
Behavioral: questionnaires
Patients will be evaluated at one time point using the Breast Sensation Assessment Score (BSAS©), the SF-36 Health Survey, the MSKCC BREAST Q, the Brief Pain Inventory, the Hopwood Body Image Scale, the Profile of Mood States -Brief Version (POMS - BRF), and the 'Patient Demographic and Treatment Information Form'
3
mastectomy alone
Behavioral: questionnaires
Patients will be evaluated at one time point using the Breast Sensation Assessment Score (BSAS©), the SF-36 Health Survey, the MSKCC BREAST Q, the Brief Pain Inventory, the Hopwood Body Image Scale, the Profile of Mood States -Brief Version (POMS - BRF), and the 'Patient Demographic and Treatment Information Form'

  Eligibility
Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample

Study Population

MSKCC clinics


Criteria

Inclusion Criteria:

  • The Samples used will be derived from three cohorts below and will only include patients who have completed mastectomy or reconstruction within 1-3 years of enrollment.
  • Patients who have undergone immediate, two-stage expander/implant postmastectomy reconstruction
  • Patients who have undergone immediate, autogenous tissue flap reconstruction following mastectomy
  • Patients who have undergone mastectomy alone
  • Patients at least 21 years of age
  • Patients who completed mastectomy ± immediate post-mastectomy reconstruction at least one year but no longer than three years prior to study entry

Exclusion Criteria:

  • Patients who have had any of the following:
  • delayed reconstruction (no reconstruction at time of surgery) combined autogenous tissue/implant breast reconstruction, and/or
  • Patients who have a pre-surgical history of complex regional pain syndrome
  • Patients who have had radiation therapy
  • Patients who have had a local recurrence
  • Patients who do not speak the English language (validated translations of key questionnaires are not available).
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00625924

Contacts
Contact: Andrea Pusic, MD     pusica@mskcc.org    
Contact: Babak Mehrara     mehrarab@mskcc.org    

Locations
United States, New York
Memorial Sloan Kettering Cancer Center     Recruiting
      New York, New York, United States, 10065
      Contact: Andrea Pusic, MD         pusica@mskcc.org    
      Contact: Babak Mehrara, MD         mehrarab@mskcc.org    
      Principal Investigator: Adrea Pusic, MD            

Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center

Investigators
Principal Investigator:     Andrea Pusic, MD     Memorial Sloan-Kettering Cancer Center    
  More Information

Memorial Sloan-Kettering Cancer Center  This link exits the ClinicalTrials.gov site
 

Responsible Party:   Memorial Sloan-Kettering Cancer Center ( Andrea Pusic, MD, FRCSC )
Study ID Numbers:   08-009
First Received:   February 20, 2008
Last Updated:   March 17, 2008
ClinicalTrials.gov Identifier:   NCT00625924
Health Authority:   United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
Plastic surgery  
reconstruction  

Study placed in the following topic categories:
Skin Diseases
Breast Neoplasms
Breast Diseases

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers